ЭФФЕКТИВНОСТЬ ВЫСОКОДОЗНОЙ БРАХИТЕРАПИИ ПРИ РАДИКАЛЬНОМ ЛЕЧЕНИИ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ (обзор литературы)
Аннотация
По данным литературы оценены возможности высокодозной брахитерапии с использованием иридия 192 при радикальном лучевом лечении рака предстательной железы. Сделан вывод о высокой эффективности высокодозной брахитерапии при лечении локализованного рака предстательной железы. Необходимо дальнейшее изучение возможностей высокодозной брахитерапии как в виде монотерапии, так и в виде сочетанной лучевой терапии для определения оптимальных методов лучевого лечения рака предстательной железы.
Литература
Алгоритмы диагностики и лечения больных злокачественными новообразованиями / О. Г. Суконко [и др.]. - Минск, 2012. - 589 с.
Высокодозная брахитерапия рака предстательной железы - технология будущего / В. П. Харченко [и др.] // Вопросы онкологии. - 2008. - Т. 54, № 6. - С. 765 - 767.
Довнар, О. С. Трехмерные ультразвуковые изображения в планировании высокодозовой брахитерапии при раке предстательной железы / О. С. Довнар, В. О. Амурский, В. А. Овчинников / / Ультразвуковые технологии в клинической практике: материалы конференции с международным участием / отв. ред. В. А. Овчинников. - Гродно: ГрГМУ, 2012. - С. 55-58.
Радикальная простатэктомия при локализованном и местно-распространенном раке предстательной железы / О. Г. Суконко [и др.] / Онкологический журнал. - 2007. - Т. 1, № 1(1). - С. 98 - 108.
Рак предстательной железы [Electronic resource] / A. Heidenreich [et al.]; пер. О. В. Антонова; науч. ред.: Б. Я. Алексеев, К. М. Нюшко // ЕАУ. - 2010. - Mode of access: http://www.uroweb.org/gls/pdf/russian/3_Prostate_Cancer.pdf. Date of access: 06.03.2013.
Роль брахитерапии в радикальном лечении рака предстательной железы / Г. А. Паньшин [и др.] // Вопросы онкологии. - 2006. - Т. 52, № 6. - С. 663 - 669.
Способ брахитерапии рака предстательной железы: пат.13463 Респ. Беларусь, МПК А 61N 5/00(2006), А 61N 5/10(2009) / Е. Л. Слобина, О. Г. Суконко, С. Л. Поляков ; заявитель ГУ РНПЦ онкологии и медицинской радиологии им. Н. Н. Александрова. - № а 20081022; заявл. 31.03.2008; опубл. 30.04.2010 // Афiцыйны бюл. / Нац. Цэнтр. iнтэлектуал. уласнасцi. - 2010. - № 2. - С. 12.
Суконко, О. Г. Состояние и перспективы развития онкологии в Республике Беларусь / О. Г. Суконко // Онкологический журнал. - 2011. - Т. 5, № 4 (20). - С. 5-18.
2D versus 3D radiation therapy for prostate carcinoma: a direct comparison of dose volume parameters / C. A. Sale [et al.] // Acta Oncologica. - 2005. - Vol. 44, № 4. - Р. 348-354.
3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer / T. Martin [et al.] // Strahlentherapie und oncologie. - 2004. - Vol. 180, № 4. - P. 225-231.
Abdel-Wahab, M. Second primary cancer after radiotherapy for prostate cancer - A SEER analysis of brachytherapy versus external beam radiotherapy / M. Abdel-Wahab, I. M. Reis, K. Hamilton // International Journal of Radiation Oncology Biology Physics. - 2008. - Vol. 72, № 1. - P. 58-68.
American brachytherapy society prostate high-dose- rate task group / I. C. Hcu [et al.] - 2008. - Mode of access: http://www.americanbrachytherapy.org/guidelines/HDRTaskGroup.pdf. - Date of access: 16.11.2012.
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial / A. L. Zietman [et al.] // Journal of the American Medical Association - 2005. - Vol. 294, № 10. - P. 1233-1239.
Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT // I. Deutsch [et al.] // Brachytherapy. - 2010. - Vol. 9, № 4. - P. 313-318.
Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience / T. Satoh [et al.] // Japanese Journal of Radiology. - 2009. - Vol. 27. - P. 348-354.
Demanes, D. J. High-dose-rate brachytherapy of prostate cancer / D. J. Demanes, D. R. Hill // California Endocurietherapy Cancer Center, Oakland [Electronic resource]. - 2007 - Mode of access: http:// www.touchoncology.com/system/files/private/articles/18618/pdf/hill.pdf. - Date of access: 27.03.2013.
Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy / A. A. Martinez [et al.] // International Journal of Radiation Oncology Biology Physics. - 2002. - Vol. 79, № 2. - P. 363-370.
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer / A. A. Martinez [et al.] // International Journal of Radiation Oncology Biology Physics. - 2002. - Vol. 53, № 2. - P. 316-327.
Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer / G. Frohlich [et al.] // Strahlentherapie und Onkologie. - 2010. - Vol. 186, № 7. - P. 388-395.
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost / A. K. Singh [et al.] // Radiation Oncology [Electronic resource]. - 2006, № 1:28. – Mode of access:http://www.ro-journal.com/content/pdf/1748-717X-1-28.pdf. -Data of access: 27.02.2013.
Evans, M. Radical radiotherapy for prostate cancer / E. Mererid, M. Mason // Urological Cancers. - 2005. - Part 1. - P. 48 - 59.
Experiences with a new high-dose-rate brachytherapy (HDRBT) boost technique for T3b prostate cancer / D. Rades [et al.] // Strahlentherapie und Onkologie. - 2007. - Vol. 183, № 7. - P. 398-402.
Gulley, J. L. Prostate cancer / Updates in radiation therapy for prostate cancer: dose matters / J. L. Gulley, E. C. White [et al.]. - New York: Demos Medical Publishing, 2011. - P. 481-500.
High dose brachytherapy (real time) in patients with intermediate- or high-risk prostate cancer: technical description and preliminary experience / P. J. Prada [et al.] // Clinical Translation Oncology. - 2005. - Vol. 7, № 9. - P. 389-397.
High dose Rate (HDR) Monotherapy is equivalent to combined HDR brachytherapy and external beam radiation therapy (EBRT) for early prostate cancer / D. Demanes [et al.] // Proceedings of the 48th Annual ASTRO Meeting. Philadelphia, 2006. - № 2253 - P. 351. [Electronic resource]. - Mode of access: http://astro2006.abstractsnet.com/acover.wcs?entryid=000715. - Date of access: 27.03.2013.
High dose rate brachyterapy as monotherapy for clinically localized prostate cancer / L. Rogers [et al.]. - [Electronic resource]. – 2006. Mode of access: http://www.gammawest.com/publications/high_does_brachytherapy.pdf. - Date of access: 25.03.2013.
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds / I. S. Grills [et al.] // Journal of Urology. - 2004.- Vol. 171, № 3. - P. 1098-1104.
High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report / T. P. Mate // International Journal of Radiation Oncology Biology Physics. - 1998. - Vol. 41, № 3. - P. 525-533.
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results / D. J. Demanes [et al.] // International Journal of Radiation Oncology Biology Physics. - 2005. - Vol. 61, № 5. - P. 1306 - 1316.
High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results / N. Zamboglou [et al.] // International Journal of Radiation Oncology Biology Physics. - 2013. - Vol. 85, № 3. - P. 672-678.
High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results / P. J. Prada[et al.] // Brachytherapy. - 2012. - Vol. 11, № 2. - P. 105-110.
High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer / D. J. Demanes [et al.] // International Journal of Radiation Oncology Biology Physics. - 2011. - Vol. 81, № 5. - P. 1286-1292.
Image-guided radiotherapy: a new dimension in radiation oncology / J. F. Sterzing [et al.] // Deutsches Arzteblatt Intternational. - 2011. - Vol. 108, № 16. - P. 274-280.
Image-guided stereotactic body radiation therapy for clinically localized prostate cancer: preliminary clinical results / G. Bolzicco [et al.] // Technology in cancer research and treatment. - 2010. - Vol. 9, № 5. - P. 473-477.
Interstitial high-dose-rate brachytherapy as monotherapy for early stage prostate cancer: median 8-Year Results in 317 patients / R. J. Mark [et al.] // Brachytherapy. - 2011. - Vol. 10, № 1. - P. S17.
Ismail, M. Androgen suppression strategies for prostate cancer: is there an ideal approach? / M. Ismail, M. Ferroni, L. G. Gomella // Current Urology Reports. - 2011. - № 12. - P. 188-196.
Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer / P. J. Prada // Radiation Oncology [Electronic resource]. - 2012. - Vol. 7, № 31. - Mode of access: http://www.rojournal.com/content/7/1/31. - Data of access: 29.03.2013.
Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer / R. M. Galalae [et al.] // International Journal of Radiation Oncology Biology Physics. - 2002. - Vol. 52, № 1. - P. 81- 90.
Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer / L. L. Kestin [et al.] // Journal of Clinical Oncology. - 2000. - Vol 18, № 15. - P. 2869-2880.
Neoadjuvant androgen deprivation and long-term results for patients with intermediate-and high-risk prostate cancer treated with high-dose rate brachytherapy and external beam radiotherapy / A. C. Pellizzon [et al.] // Applied cancer research [Electronic resource]. - 2010. - Vol. 30, № 3. - Mode of access: http://www.appliedcr.org.br/detalhe_artigo.asp?id=17. - Data of access: 29.03.2013.
Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer / M. Roach [et al.] // International Journal of Radiation Oncology Biology Physics. - 1994. - Vol. 28, № 1. - P. 33-37.
Ten -year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer / Z. A. Alicikus [et al.] // Cancer. - 2011. - Vol. 117, № 7. - P. 1429-1437.
